
CN Bio
CN Bio is a close-knit team of passionate scientists, engineers and creative thinkers, all working together towards a shared goal – a future where drugs are discovered more quickly, brought to patients more cost-effectively and with less animal experimentation. Day to day, their cohesive team design, manufacture, promote and support organ-on-a-chip solutions that enable their customers to do something incredible – recreate three-dimensional human organs and tissues in the laboratory to improve understanding of human physiology, disease and the effectiveness of new drugs.
Latest CN Bio Content

CN Bio Launches PhysioMimix DILI Assay Kit: Human 24, for Enhanced Preclinical Toxicology Testing

CN Bio Signs Strategic Partnership With Primetech Corporation To Establish Distribution Channel for OOC Solutions in Japan

CN Bio Launches PhysioMimix Bioavailability Assay Kit: Human 18

A Reflection on Global Fatty Liver Day 2024: How Organ-on-a-Chip Addresses R&D Challenges

CN Bio and Altis Biosystems Partner To Develop Next-Generation Human Gut/Liver In Vitro Model

CN Bio PhysioMimix Organ-on-a-Chip Data Supports Inipharm’s INI-822 for Metabolic Liver Disease Treatment

CN Bio and LifeNet Health LifeSciences Partner To Supply Validated Primary Human Cells for Microphysiological Systems

CN Bio Extends Microphysiological System Portfolio

The FDA Expands Collaboration With CN Bio To Evaluate Multi-Organ Microphysiological System
